Carroll Financial Associates’s VivoSim Labs VIVS Stock Holding History

Carroll Financial Associates’s Portfolio VIVS Stock Details VIVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-4	Closed	–	–	1751
2019 Q2	$0	Hold	4	–	–	﹤0.01%	1745
2019 Q1	$0	Hold	4	–	–	﹤0.01%	1538
2018 Q4	$1K	Hold	4	–	–	﹤0.01%	1268
2018 Q3	$1K	Hold	4	–	–	﹤0.01%	1286
2018 Q2	$1K	Hold	4	–	–	﹤0.01%	1243
2018 Q1	$1K	Hold	4	–	–	﹤0.01%	1232
2017 Q4	$1K	Hold	4	–	–	﹤0.01%	1208
2017 Q3	$2K	Hold	4	–	–	﹤0.01%	1118
2017 Q2	$2K	Hold	4	–	–	﹤0.01%	1113
2017 Q1	$3K	Hold	4	–	–	﹤0.01%	1072
2016 Q4	$3K	Hold	4	–	–	﹤0.01%	1030
2016 Q3	$3K	Buy	+4	New	+$3.92K	﹤0.01%	1043

Other funds holding VIVS

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Winton Group London, United Kingdom $2.85B AUM 30.73% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Carroll Financial Associates's VIVS Position: Q3 2019 in Review

Carroll Financial Associates sold out of VivoSim Labs (VIVS) in Q3 2019, closing a stake of 4 shares.

Carroll Financial Associates first reported a position in VIVS in Q3 2016 and held it in 12 quarters. The position peaked at $3K in Q1 2017. 78 funds tracked by Wall St. Rank hold VIVS as of Q3 2019.

Carroll Financial Associates reported no remaining VivoSim Labs position as of Q3 2019 after selling out during the quarter.
Carroll Financial Associates sold 4 VivoSim Labs shares in Q3 2019.
Carroll Financial Associates first reported a position in VivoSim Labs in Q3 2016 and held it in 12 quarters.
Carroll Financial Associates's VivoSim Labs position peaked at $3K in Q1 2017.
78 funds tracked by Wall St. Rank held VivoSim Labs as of Q3 2019.

Based on Carroll Financial Associates's 13F filing for Q3 2019, filed 9 Oct 2019.